Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ACD-A¿¡ ¾Æ³ªÇʶô½Ã½º¸¦ º¸ÀΠȯÀÚ¿¡¼­ UFHÀ» ´Üµ¶À¸·Î »ç¿ëÇÑ Ç÷À屳ȯ¼ú 2·Ê Two Cases of Successful Plasma Exchange with Unfractionated Heparin Anticoagulation in Patients Exhibiting Anaphylaxis to Acid-citrate-dextrose Formula A

´ëÇѼöÇ÷ÇÐȸÁö 2020³â 31±Ç 1È£ p.55 ~ 60
°­ÇýÀÎ, ±èµµÈÆ, Àüµ¿¼®, ÀÌ¿ø¸ñ, ·ù³²Èñ, ÇÏÁ¤¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
°­ÇýÀΠ( Kang Hye-In ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine

±èµµÈÆ ( Kim Do-Hoon ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine
Àüµ¿¼® ( Jeon Dong-Seok ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine
ÀÌ¿ø¸ñ ( Lee Won-Mok ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine
·ù³²Èñ ( Ryoo Nam-Hee ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine
ÇÏÁ¤¼÷ ( Ha Jung-Sook ) 
Keimyung University Dongsan Hospital Department of Laboratory Medicine

Abstract


Plasma exchange performed with the aid of acid-citrate-dextrose formula A (ACD-A) is generally regarded as safe. However, unfractionated heparin (UFH) can serve as an anticoagulant for patients experiencing serious side effects such as anaphylaxis. No guidelines have currently been defined for the stand-alone UFH dosing during plasma exchange. We describe here two patients who developed anaphylaxis to ACD-A during plasma exchange, and we successfully used UFH as a standalone anticoagulant. The first patient was a 55-year-old man who required plasma exchange before ABO-incompatible kidney transplantation. During plasma exchange, he developed an allergic reaction. Thereafter, UFH was used as a standalone anticoagulant during four sessions of plasma exchange; the UFH (5,000 units) was added to a 500 mL normal saline bag and the UFH:whole blood ratio was maintained at 1:28. The second patient was an 80-year-old woman with steroid pulse-resistant neuromyelitis optica. She developed an allergic reaction during the first session of plasma exchange. The patient subsequently underwent five successful sessions of plasma exchange using UFH as a standalone anticoagulant. These findings may be useful when establishing a protocol for UFH as a standalone anticoagulant during plasma exchange in patients who develop an allergic reaction to citrate.

Å°¿öµå

Plasma exchange; Heparin; Anticoagulation

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS